Transcatheter aortic valve implantation in Asia: the first decade

  • Eurointervention 2018; 14: 35-37.

Last year, the interventional cardiology community commemorated the 15th anniversary of the birth of transcatheter aortic valve implantation (TAVI)1. Since European commercial approval was granted in 2007, the expansion and uptake of TAVI in Europe has been phenomenal2.

In comparison, TAVI only reached the shores of Asia two years later, when the procedure was first performed in Singapore in February 2009, using the SAPIEN valve (Edwards Lifesciences, Irvine, CA, USA)3. Subsequently, CoreValve® (Medtronic, Minneapolis, MN, USA) was launched commercially in Malaysia in October 2009.…

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google